| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |